PEDIATRIX MEDICAL GROUP INC (MD) Stock Earnings & Estimates
NYSE:MD - US58502B1061 - Common Stock
17.21 USD
+0.11 (+0.64%)
17.21 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.972B 3.18% | 1.995B 1.15% | 2.013B 0.92% | 1.94B -3.62% | 2B 3.09% | 2.096B 4.80% | 2.204B 5.15% | 2.309B 4.76% | |
| EBITDA YoY % growth | 235.636M -5.70% | 194.023M -17.66% | 215.907M 11.28% | 239.54M 10.95% | 248.83M 3.88% | 258.57M 3.91% | N/A | N/A | |
| EBIT YoY % growth | 200M -8.15% | 157.852M -21.07% | 183.681M 16.36% | 228.44M 24.37% | 233.23M 2.10% | 242.61M 4.02% | N/A | N/A | |
| Operating Margin | 10.14% | 7.91% | 9.13% | 11.78% | 11.66% | 11.57% | N/A | N/A | |
| EPS YoY % growth | 1.67 2.45% | 1.26 -24.55% | 1.49 18.25% | 1.85 24.34% | 1.90 2.47% | 1.98 4.54% | 1.82 -8.15% | 1.79 -1.69% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.48 9.76% | 0.48 -6.06% | 0.36 8.87% | 0.50 -6.26% | 0.51 5.61% | 0.52 8.39% | 0.36 0.92% | 0.58 17.21% | 0.55 7.03% | 0.54 3.47% |
| Revenue Q2Q % growth | 490.2M -4.10% | 495.32M -1.40% | 486.23M 6.08% | 497.66M 6.15% | 509.47M 3.93% | 519.43M 4.87% | 508.45M 4.57% | 522.63M 5.02% | 522.8M 2.62% | 540.27M 4.01% |
| EBITDA Q2Q % growth | 66.41M -14.64% | 66.89M -25.95% | 52.667M 19.59% | 68.357M -8.06% | 69.671M 4.91% | 72.025M 7.68% | 52.67M 0.01% | 82.011M 19.97% | 73.738M 5.84% | 74.669M 3.67% |
| EBIT Q2Q % growth | 59.502M 13.45% | 59.567M 2.52% | 45.99M 18.82% | 65.806M 3.30% | 63.51M 6.74% | 64.943M 9.03% | 46.52M 1.15% | 75.697M 15.03% | 67.419M 6.15% | 67.922M 4.59% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.53 55.88% | 0.44 | 0.09 | 21.14% |
| Q1 2025 Q2Q % growth | 0.33 65.00% | 0.25 | 0.08 | 32.73% |
| Q4 2024 Q2Q % growth | 0.51 59.38% | 0.38 | 0.13 | 34.96% |
| Q3 2024 Q2Q % growth | 0.44 37.50% | 0.38 | 0.06 | 15.90% |
| Q2 2024 Q2Q % growth | 0.34 -12.82% | 0.32 | 0.02 | 5.21% |
| Q1 2024 Q2Q % growth | 0.20 -13.04% | 0.19 | 0.01 | 4.25% |
| Q4 2023 Q2Q % growth | 0.32 -31.91% | 0.33 | -0.01 | -4.41% |
| Q3 2023 Q2Q % growth | 0.32 -20.00% | 0.45 | -0.13 | -28.23% |
| Q2 2023 Q2Q % growth | 0.39 -17.02% | 0.41 | -0.02 | -5.81% |
| Q1 2023 Q2Q % growth | 0.23 -30.30% | 0.24 | -0.01 | -2.38% |
| Q4 2022 Q2Q % growth | 0.47 -9.62% | 0.50 | -0.03 | -5.68% |
| Q3 2022 Q2Q % growth | 0.40 -13.04% | 0.56 | -0.16 | -29.04% |
| Q2 2022 Q2Q % growth | 0.47 14.63% | 0.49 | -0.02 | -4.02% |
| Q1 2022 Q2Q % growth | 0.33 37.50% | 0.28 | 0.05 | 17.55% |
| Q4 2021 Q2Q % growth | 0.52 108.00% | 0.45 | 0.07 | 15.71% |
| Q3 2021 Q2Q % growth | 0.46 24.32% | 0.43 | 0.03 | 7.43% |
| Q2 2021 Q2Q % growth | 0.41 28.12% | 0.33 | 0.08 | 22.72% |
| Q1 2021 Q2Q % growth | 0.24 -25.00% | 0.14 | 0.10 | 75.63% |
| Q4 2020 Q2Q % growth | 0.25 -72.53% | 0.37 | -0.12 | -31.88% |
| Q3 2020 Q2Q % growth | 0.37 -59.34% | 0.42 | -0.05 | -10.88% |
| Q2 2020 Q2Q % growth | 0.32 -64.04% | 0.09 | 0.23 | 248.30% |
| Q1 2020 Q2Q % growth | 0.32 -50.77% | 0.56 | -0.24 | -42.56% |
| Q4 2019 Q2Q % growth | 0.91 | 0.93 | -0.02 | -1.99% |
| Q3 2019 Q2Q % growth | 0.91 | 0.93 | -0.02 | -2.38% |
| Q2 2019 Q2Q % growth | 0.89 | 0.88 | 0.01 | 0.74% |
| Q1 2019 Q2Q % growth | 0.65 | 0.72 | -0.07 | -9.62% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 468.844M -7.03% | 478.25M | -9.406M | -1.97% |
| Q1 2025 Q2Q % growth | 458.359M -7.42% | 465.04M | -6.681M | -1.44% |
| Q4 2024 Q2Q % growth | 502.364M 1.19% | 500.79M | 1.574M | 0.31% |
| Q3 2024 Q2Q % growth | 511.158M 0.90% | 513.83M | -2.672M | -0.52% |
| Q2 2024 Q2Q % growth | 504.296M 0.74% | 520.66M | -16.364M | -3.14% |
| Q1 2024 Q2Q % growth | 495.101M 0.83% | 514.05M | -18.949M | -3.69% |
| Q4 2023 Q2Q % growth | 496.443M -3.39% | 539.04M | -42.597M | -7.90% |
| Q3 2023 Q2Q % growth | 506.612M 3.41% | 523.5M | -16.888M | -3.23% |
| Q2 2023 Q2Q % growth | 500.577M 2.99% | 510.73M | -10.153M | -1.99% |
| Q1 2023 Q2Q % growth | 491.008M 1.82% | 505.5M | -14.492M | -2.87% |
| Q4 2022 Q2Q % growth | 513.844M 3.07% | 517.05M | -3.206M | -0.62% |
| Q3 2022 Q2Q % growth | 489.915M -0.62% | 527.11M | -37.195M | -7.06% |
| Q2 2022 Q2Q % growth | 486.033M 2.76% | 506.28M | -20.247M | -4.00% |
| Q1 2022 Q2Q % growth | 482.229M 7.93% | 488.42M | -6.191M | -1.27% |
| Q4 2021 Q2Q % growth | 498.53M 19.67% | 498.34M | 190K | 0.04% |
| Q3 2021 Q2Q % growth | 492.949M 7.02% | 494.45M | -1.501M | -0.30% |
| Q2 2021 Q2Q % growth | 472.959M 13.86% | 462.41M | 10.549M | 2.28% |
| Q1 2021 Q2Q % growth | 446.8M 1.27% | 436.85M | 9.95M | 2.28% |
| Q4 2020 Q2Q % growth | 416.6M -9.16% | 473.33M | -56.73M | -11.99% |
| Q3 2020 Q2Q % growth | 460.6M 112.36% | 551.45M | -90.85M | -16.47% |
| Q2 2020 Q2Q % growth | 415.4M -25.98% | 572.6M | -157.2M | -27.45% |
| Q1 2020 Q2Q % growth | 441.2M -18.75% | 878.02M | -436.82M | -49.75% |
| Q4 2019 Q2Q % growth | 458.6M | 928.24M | -469.64M | -50.59% |
| Q3 2019 Q2Q % growth | 216.9M | 902.53M | -685.63M | -75.97% |
| Q2 2019 Q2Q % growth | 561.2M | 894.76M | -333.56M | -37.28% |
| Q1 2019 Q2Q % growth | 543M | 933.6M | -390.6M | -41.84% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 7.05% | 10.98% | 8.04% | 10.45% |
| Revenue | 0.64% | 0.44% | 0.52% | 0% |